Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-3.19	28.76	29.71
Graham Fair Price	39.00	2.14	1.54
PEG	inf	0.00	0.11
Price/Book	4.98	9.71	9.25
Price/Cash Flow	2.80	37.03	36.02
Prices/Earnings	-8.74	11.12	12.18
Price/Sales	18.85	11.30	9.51
Price/FCF	2.80	37.03	36.02
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	6.01	0.72	0.68
Operating Margin	24.99	0.35	0.28
ROA	39.49	0.01	0.01
ROE	0.19	0.22	15.04
ROIC	0.14	0.18	33.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.02	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.04	0.00	inf
EPS QOQ	1.09	0.00	inf
FCF QOQ	-0.78	0.00	inf
Revenue QOQ	1.20	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	51.14	15.50	-69.70
Inventory Turnover	233000000.00	0.00	inf
Debt/Capitalization	0.30	0.18	-40.42
Quick Ratio	0.43	25.02	5708.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	0.74	0.96	29.60
Cash	5.25	5.02	-4.49
Capex	< 0.005	< 0.005	-85.02
Free Cash Flow	0.19	0.25	32.35
Revenue	0.72	0.83	14.48
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	1.05	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.85	-2.77	2.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating